ASN
DYN icon

Advisory Services Network’s Dyne Therapeutics DYN Stock Holding History

Advisory Services Network’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29
Closed -$526 – 2840
2026
Q1 		$526 Buy
+29
New +$500 ﹤0.01% 4415
2025
Q4 		– Sell
-14
Closed -$177 – 2478
2025
Q3 		$177 Buy
+14
New +$160 ﹤0.01% 4237

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Advisory Services Network's DYN Position: Q2 2026 in Review

Advisory Services Network sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 29 shares — an estimated $526 sold.

Advisory Services Network first reported a position in DYN in Q3 2025 and held it in 2 quarters. The position peaked at $526 in Q1 2026. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Advisory Services Network reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 29 Dyne Therapeutics shares in Q2 2026, an estimated $526.
  • Advisory Services Network first reported a position in Dyne Therapeutics in Q3 2025 and held it in 2 quarters.
  • Advisory Services Network's Dyne Therapeutics position peaked at $526 in Q1 2026.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.